Zentiva
Jan Krechl is a seasoned professional in the field of digital innovation and project management with extensive experience in the pharmaceutical and research sectors. Currently serving as Digital Innovation Manager at Zentiva, Jan is spearheading initiatives to utilize artificial intelligence in generic drug research and development. With a strong background in managing value-added medicine projects and evaluating R&D initiatives as a member of the Programmes Board at Technologická agentura České republiky, Jan has demonstrated expertise in leading global project deliveries at Signant Health. Previous roles include managing various departments within the Technology Agency of the Czech Republic, focusing on supporting research and development mechanisms and public procurement processes. Jan holds an Ing. degree in Finance from Bankovní institut vysoká škola - Praha and a Bc. degree in Management ICT from the College of Information Management and Business Administration.
This person is not in any teams
Zentiva
5 followers
Zentiva is a Pan-European Platform developing, manufacturing and providing high-quality and affordable medicines to more than 100 million people in Europe. Zentiva has 4 wholly owned manufacturing sites and a broad network of external manufacturing partners to ensure supply security. We offer solutions in key therapeutical areas like Cardiology & Circulation, Diabetes, Oncology, Respiratory, CNS and focus on expanding our portfolio in self-care. The company is Private Equity owned, delivering sustainable double-digit growth, with an ambitious 5-year plan for further strong (organic and inorganic) growth across Europe. We are a team of almost 5,000 unique talents bonded together by our mission to deliver high-quality and affordable medicines to people who depend on them every day. We want Zentiva to be a great place to work, where everyone feels welcomed and appreciated and can be their true selves contributing to the best of their ability.